Search Results for keywords:"Health and Human Services"

In January 2025, the Drug Enforcement Administration and the Department of Health and Human Services published new rules about expanding telemedicine practices. These rules were supposed to take effect on February 18, 2025, but have been delayed to March 21, 2025. This delay aligns with a Presidential order for a "Regulatory Freeze Pending Review," allowing more time for feedback on the rules. The rules allow certain medical professionals to prescribe medications via telemedicine, even without an initial in-person visit, under specific conditions. Public comments about this delay are encouraged, focusing on potential policy, legal, and factual issues.

The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the Department of Health and Human Services, announced additional funding for five grant recipients from the FY 2020 National Consumer and Consumer Supporter Technical Assistance Centers initiative. The extra funding totals $1,806,000, allowing each recipient to receive up to $361,200. This funding will extend their projects by 12 months, until March 30, 2026, enabling them to continue supporting mental health services for adults with serious mental illness. These funds are only available to the original grant recipients who demonstrate satisfactory applications and budgets.

The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a final rule updating the regulations for the National Institute on Minority Health and Health Disparities (NIMHD) Research Endowment Programs. This rule expands eligibility for research endowment awards to include certain Health Resources and Services Administration and NIMHD centers of excellence, following the enactment of Public Law 117-104. It also changes the program's name to honor John Lewis and revises outdated regulatory references. The changes aim to improve research capacity in minority health and address health disparities while adhering to current laws and guidelines.

The Department of Health and Human Services (HHS) has delayed the effective date of a final rule concerning updates to the Health Insurance Portability and Accountability Act (HIPAA) standards for retail pharmacy transactions and Medicaid pharmacy subrogation until April 14, 2025. This delay, following a Presidential memorandum on regulatory review, allows HHS more time to consider the new regulations. The compliance date for these standards is also extended to April 14, 2028. The immediate implementation of this delay is based on good cause exceptions, as it is impractical to seek public comment given the circumstances.

The Center for Scientific Review Advisory Council is holding a public meeting on March 29, 2021, from 1:00 p.m. to 4:30 p.m. The meeting will be conducted virtually at the National Institutes of Health in Bethesda, MD, and aims to provide advice to the director of the Center for Scientific Review on various matters related to grant applications. Attendees can access the meeting online at https://videocast.nih.gov or visit https://public.csr.nih.gov/​AboutCSR/Organization/CSRAdvisoryCouncil for more information. For details or accommodations, individuals should contact Bruce Reed, Ph.D., the Deputy Director, at reedbr@mail.nih.gov.

The Agency for Healthcare Research and Quality (AHRQ) is seeking additional scientific information from the public to assist with a systematic review on managing menopausal symptoms in perimenopausal and early postmenopausal women. This review is being conducted by AHRQ's Evidence-based Practice Centers (EPC) Program to improve its quality by considering both published and unpublished relevant studies. People and organizations are invited to submit completed and ongoing study details, which should be public or able to be made public, by April 17, 2025. The review will explore questions related to the effectiveness and safety of treatments for menopausal symptoms, as well as individual and system-level factors influencing treatment.

The Food and Drug Administration (FDA) is reopening the period during which the public can submit comments on the document titled "Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products." Originally published on July 25, 2024, this reopening allows for updated or new information to be submitted, with a final deadline for comments set for March 3, 2025. Comments can be submitted electronically online or in written form to the FDA's Dockets Management Staff. Submissions must include the specific docket number and any confidential information must be clearly marked and handled as per FDA guidelines.

The Food and Drug Administration (FDA) is opening the floor for public comments about a new collection of information related to animal drugs and veterinary master files. This initiative is part of the Paperwork Reduction Act, requiring federal notices about such collections and giving the public 60 days to comment. The FDA aims to gather insights on whether the information collection is necessary, its accuracy, and how to minimize the efforts needed from participants. Interested parties can submit their comments electronically or in written form by February 28, 2025.

The National Institute of Allergy and Infectious Diseases (NIAID) announced two upcoming closed meetings as required by law. These meetings, scheduled for January 28-29, 2021, will focus on reviewing and evaluating contract proposals related to Small Business Innovation Research. The discussions are closed to the public to protect confidential information and personal privacy. Interested parties can contact Soheyla Saadi, Ph.D., for more information.

The Administration for Children and Families, part of the U.S. Department of Health and Human Services, is seeking public comments on extending and updating the Low Income Home Energy Assistance Program (LIHEAP) Performance Measures. This involves continuing the current data collection until June 2025 and introducing changes starting July 2025. These changes aim to collect more detailed data on the impact of federal funds and improve survey tools. The general public, especially those interested in the program, can submit their comments by January 31, 2025.